Maatman TJ - Search Results

1

Gene expression profiling of renal cell carcinoma.

Tan MH, Rogers CG, Cooper JT, Ditlev JA, Maatman TJ, Yang X, Furge KA, Teh BT. Tan MH, et al. Among authors: maatman tj. Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6315S-21S. doi: 10.1158/1078-0432.CCR-050002. Clin Cancer Res. 2004. PMID: 15448024 Review.

2

The benign appearance of Wilms' tumor.

Maatman T, Kay R. Maatman T, et al. Cleve Clin Q. 1983 Fall;50(3):279-82. doi: 10.3949/ccjm.50.3.279. Cleve Clin Q. 1983. PMID: 6317228 No abstract available.

3

Solitary pseudo-crossed renal ectopia.

Maatman TJ, DeOreo GA Jr, Kay R. Maatman TJ, et al. J Urol. 1983 Jan;129(1):128-9. doi: 10.1016/s0022-5347(17)51955-2. J Urol. 1983. PMID: 6402608 No abstract available.

4

Reply by Authors.

Wang Y, Wilder S, Van Til M, Qi J, Mirza M, Gadzinski A, Maatman T, Lane BR, Rogers CG. Wang Y, et al. Urol Pract. 2024 Jan;11(1):134. doi: 10.1097/UPJ.0000000000000478.04. Epub 2023 Nov 29. Urol Pract. 2024. PMID: 38117966 No abstract available.

5

Comparative analysis of prognostic factors in men undergoing radical prostatectomy for adenocarcinoma of the prostate, including DNA ploidy, surgical tumor stage, prostatic specific antigen, Gleason grade, and age.

Shockley KF, Maatman TJ, Carothers GC, Warzynski MJ. Shockley KF, et al. Among authors: maatman tj. Prostate. 1996 Jul;29(1):46-50. doi: 10.1002/(SICI)1097-0045(199607)29:1<46::AID-PROS7>3.0.CO;2-G. Prostate. 1996. PMID: 8685055

6

Simplified management of post-prostate biopsy rectal bleeding.

Maatman TJ, Bigham D, Stirling B. Maatman TJ, et al. Urology. 2002 Sep;60(3):508. doi: 10.1016/s0090-4295(02)01772-7. Urology. 2002. PMID: 12350498

7

Pain perception during transrectal ultrasound guided prostate needle biopsy: an objective analysis of local anesthesia use.

Stirling BN, Shockley KF, Carothers GG, Maatman TJ. Stirling BN, et al. Among authors: maatman tj. Prostate Cancer Prostatic Dis. 2002;5(3):209-11. doi: 10.1038/sj.pcan.4500598. Prostate Cancer Prostatic Dis. 2002. PMID: 12496983 Clinical Trial.

8

The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate.

Maatman TJ. Maatman TJ. J Urol. 1989 Jun;141(6):1378-80. doi: 10.1016/s0022-5347(17)41313-9. J Urol. 1989. PMID: 2470927

9

DNA heterogeneity determined by flow cytometry in prostatic adenocarcinoma--necessitating multiple site analysis.

Warzynski MJ, Soechtig CE, Maatman TJ, Goldsmith LC, Grobbel MA, Carothers GG, Shockley KF. Warzynski MJ, et al. Among authors: maatman tj. Prostate. 1995 Dec;27(6):329-35. doi: 10.1002/pros.2990270606. Prostate. 1995. PMID: 7501545

10

Comparative analysis of fluctuation of serum tumor markers in advanced cancer of prostate.

Maatman TJ. Maatman TJ. Urology. 1993 Dec;42(6):672-6. doi: 10.1016/0090-4295(93)90531-e. Urology. 1993. PMID: 7504849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters